Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy
- PMID: 21108935
- DOI: 10.1016/j.brainres.2010.11.044
Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy
Abstract
Glioblastoma (GBM) is a highly aggressive brain tumor characterized by increased proliferation and resistance to chemotherapy and radiotherapy. A growing body of evidence suggests that only a small subpopulation of malignant glioma cells, called glioma stem cells or glioma-initiating cells (GICs), have true tumorigenic potential and confer glioma radioresistance. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) plays a major role in the repair of DNA double-strand breaks induced by ionizing radiation (IR). Suppression of one of these components of the DNA-PK complex can inhibit the DNA double-strand break repair and radiosensitize the cells. In general, the cell death induced by IR is considered to be apoptotic. Recently, autophagy, an alternative form of programmed cell death, has been shown to contribute significantly to anti-neoplastic effects of radiation therapy. Autophagy is independent of phagocytes and differs from apoptosis by the presence of autophagosomes, autolysosomes, and an intact nucleus in the cell. Little is known, however, regarding the relationship between DNA-PKcs and IR-induced autophagy in GICs. In the present study, we constructed plasmids encoding short hairpin RNA (shRNA) targeting DNA-PKcs, which were then transfected into GICs. Then, we used GICs and DNA-PKcs-RNAi transfected cells to investigate the role of DNA-PKcs in IR-induced apoptotic and autophagic cell death. IR induced massive autophagic cell death in DNA-PKcs-RNAi transfected cells, but only occasional apoptotic cells were detected among GICs. Specific inhibition of DNA-PKcs in GICs induced autophagy and radiosensitized the cells. Our results suggest that such radiation-induced autophagy may enhance the effect of glioma therapies.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy.Cancer Res. 2005 May 15;65(10):4368-75. doi: 10.1158/0008-5472.CAN-04-4202. Cancer Res. 2005. PMID: 15899829
-
DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.J Cell Physiol. 2015 May;230(5):1094-103. doi: 10.1002/jcp.24841. J Cell Physiol. 2015. PMID: 25294801
-
Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.Radiother Oncol. 2011 Oct;101(1):51-8. doi: 10.1016/j.radonc.2011.06.037. Epub 2011 Aug 16. Radiother Oncol. 2011. PMID: 21852011
-
Mechanisms regulating radiosensitivity of glioma stem cells.Neoplasma. 2017;64(5):655-665. doi: 10.4149/neo_2017_502. Neoplasma. 2017. PMID: 28592117 Review.
-
The role of autophagy in sensitizing malignant glioma cells to radiation therapy.Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):341-51. doi: 10.1093/abbs/gmp028. Acta Biochim Biophys Sin (Shanghai). 2009. PMID: 19430698 Review.
Cited by
-
Cancer stem cells and chemoresistance: The smartest survives the raid.Pharmacol Ther. 2016 Apr;160:145-58. doi: 10.1016/j.pharmthera.2016.02.008. Epub 2016 Feb 17. Pharmacol Ther. 2016. PMID: 26899500 Free PMC article. Review.
-
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets.Cell Oncol (Dordr). 2021 Oct;44(5):961-981. doi: 10.1007/s13402-021-00613-0. Epub 2021 May 31. Cell Oncol (Dordr). 2021. PMID: 34057732 Review.
-
NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro.Acta Pharmacol Sin. 2013 May;34(5):681-90. doi: 10.1038/aps.2013.22. Epub 2013 Apr 22. Acta Pharmacol Sin. 2013. PMID: 23603977 Free PMC article.
-
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?Cancers (Basel). 2022 May 13;14(10):2416. doi: 10.3390/cancers14102416. Cancers (Basel). 2022. PMID: 35626024 Free PMC article. Review.
-
The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies.Int J Mol Sci. 2019 Aug 5;20(15):3824. doi: 10.3390/ijms20153824. Int J Mol Sci. 2019. PMID: 31387280 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical